Ignazio Olivieri

Ignazio Olivieri's AcademicInfluence.com Rankings

Ignazio Olivieri

Medical

#3378

World Rank

#3846

Historical Rank

Rheumatology

#35

World Rank

#36

Historical Rank

medical Degrees

Ignazio Olivieri

Philosophy

#9660

World Rank

#13251

Historical Rank

Logic

#6630

World Rank

#8163

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Ignazio Olivieri's Degrees

Doctorate Medicine University of Milan
PhD Rheumatology University of Milan

Why Is Ignazio Olivieri Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ignazio Olivieri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. (1991) (2214)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general (2010) (1278)
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (2011) (959)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (2015) (854)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal (2009) (780)
ASAS/EULAR recommendations for the management of ankylosing spondylitis (2005) (719)
EULAR recommendations for the management of Behçet disease (2008) (683)
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. (2005) (677)
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria (2014) (558)
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) (2009) (510)
2018 update of the EULAR recommendations for the management of Behçet’s syndrome (2018) (443)
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force (2013) (436)
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. (1995) (381)
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. (2001) (242)
Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. (2001) (219)
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease (2008) (188)
Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine (2013) (172)
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. (2001) (165)
Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. (1996) (156)
Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. (2000) (156)
Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. (2001) (152)
Proximal Bursitis in Active Polymyalgia Rheumatica (1997) (145)
Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. (2001) (141)
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. (2009) (133)
The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. (2000) (133)
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study (1999) (130)
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. (2008) (125)
Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. (1998) (124)
Diffuse idiopathic skeletal hyperostosis: Differentiation from ankylosing spondylitis (2009) (122)
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis (2006) (120)
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. (2008) (120)
Psoriasis, psoriatic arthritis, or psoriatic disease? (2006) (114)
HCV infection: pathogenesis, clinical manifestations and therapy. (2008) (112)
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study (2011) (110)
Inflammatory changes of hip synovial structures in polymyalgia rheumatica. (2005) (106)
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. (2007) (105)
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy (2008) (103)
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. (2009) (102)
Cervical interspinous bursitis in active polymyalgia rheumatica (2008) (98)
Are polymyalgia rheumatica and giant cell arteritis the same disease? (2004) (97)
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study (2016) (93)
Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia (2012) (92)
Late onset undifferentiated seronegative spondyloarthropathy. (1995) (88)
Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. (1997) (88)
Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. (1997) (85)
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. (2008) (83)
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper. (2014) (80)
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel (2010) (80)
Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging. (1998) (80)
Vascular endothelial growth factor gene polymorphisms in Behçet's disease. (2004) (78)
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis (2013) (77)
Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases? (1997) (77)
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. (2014) (76)
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. (2003) (76)
New approaches in the treatment of Adamantiades-Behçet's disease (2006) (75)
Dactylitis, a term for different digit diseases (2006) (72)
Successful treatment of SAPHO syndrome with infliximab: report of two cases (2002) (72)
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. (2002) (71)
Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. (2002) (70)
Advances in the management of psoriatic arthritis (2014) (70)
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature. (2015) (70)
Pharmacological management of SAPHO syndrome (2006) (70)
Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations (2018) (70)
Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. (1999) (69)
Efficacy of infliximab in resistant psoriatic arthritis. (2003) (69)
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. (2011) (69)
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. (2015) (69)
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. (2013) (68)
Ultrasound and Magnetic Resonance Imaging in the Evaluation of Psoriatic Dactylitis: Status and Perspectives (2013) (67)
Hepatitis C virus and arthritis. (2003) (66)
Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset (2001) (65)
7 Enthesiopathy: clinical manifestations, imaging and treatment (1998) (62)
RS3PE syndrome: an overview. (2000) (61)
Polymyalgia rheumatica: a disorder of extraarticular synovial structures? (1999) (61)
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. (2011) (61)
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease. (2001) (61)
Seronegative spondylarthropathies: imaging of spondylitis, enthesitis and dactylitis. (1998) (60)
Aortitis and periaortitis in ankylosing spondylitis. (2011) (60)
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis (2016) (60)
Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. (2004) (59)
Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases. (2012) (59)
Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. (2001) (58)
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis (2017) (58)
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. (2006) (58)
Management Issues with Elderly-Onset Rheumatoid Arthritis (2005) (57)
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. (2011) (57)
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis (2006) (57)
Diffuse idiopathic skeletal hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis. (2007) (57)
Hearing and Vestibular Disturbances in Behçet's Syndrome (1991) (55)
Psoriatic Arthritis Spondylitis Radiology Index: A Modified Index for Radiologic Assessment of Axial Involvement in Psoriatic Arthritis (2009) (54)
Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. (2006) (53)
Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. (2000) (53)
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study (2016) (52)
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. (2004) (50)
HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity (1999) (49)
Is the nail psoriasis severity index reliable in the assessment of nail psoriasis by rheumatologists? (2012) (49)
Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. (2006) (49)
Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease. (2001) (49)
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome. (2019) (49)
Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures? (2009) (49)
Psoriatic Arthritis sine Psoriasis (2009) (48)
Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders (2017) (48)
Enthesiopathy: clinical manifestations, imaging and treatment. (1998) (48)
Aortic involvement in ankylosing spondylitis. (2008) (48)
Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. (2013) (48)
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. (2010) (47)
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey (2016) (46)
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. (2008) (46)
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. (2018) (46)
Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists (2007) (45)
Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997. (2000) (44)
Therapy with cyclosporine in psoriatic arthritis. (1997) (43)
Hepatitis C virus-related arthritis. (2008) (43)
Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis (2009) (42)
Transcutaneous electrical nerve stimulation in ankylosing spondyitis: A double‐blind study (1991) (42)
Dactylitis or "sausage-shaped" digit. (2007) (42)
Role of Trauma in Psoriatic Arthritis (2008) (42)
Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. (2012) (41)
Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. (2000) (41)
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. (2009) (41)
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study (2011) (40)
Distal musculoskeletal manifestations in polymyalgia rheumatica. (2000) (40)
Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. (2001) (40)
Late onset peripheral seronegative spondyloarthropathy: report of two additional cases. (1993) (40)
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study. (2014) (39)
The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. (2007) (39)
The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis. (2017) (39)
The challenge of early diagnosis of psoriatic arthritis. (2008) (39)
Differential diagnosis between osteitis condensans ilii and sacroiliitis. (1990) (38)
Beyond Early Diagnosis: Occult Psoriatic Arthritis (2010) (38)
The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis (2018) (37)
Updated Guidelines for the Management of Axial Disease in Psoriatic Arthritis (2014) (37)
High prevalence of Behçet's disease in southern Italy. (2013) (37)
Distal extremity swelling with pitting edema in polymyalgia rheumatica: a case studied with MRI. (1997) (36)
Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis. (2002) (36)
Sensitivity of the Classification of Psoriatic Arthritis Criteria in Early Psoriatic Arthritis (2009) (36)
Remission in Nonradiographic Axial Spondyloarthritis Treated with Anti-tumor Necrosis Factor-α Drugs: An Italian Multicenter Study (2015) (35)
Spondyloarthritis with Onset After Age 45 (2013) (35)
Late-onset rheumatoid arthritis and late-onset spondyloarthritis. (2009) (35)
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases (2007) (34)
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. (2009) (34)
Remitting distal lower extremity swelling with pitting oedema in acute sarcoidosis (1997) (32)
Early treatment in early undifferentiated arthritis. (2012) (32)
Trauma and seronegative spondyloarthropathy: rapid joint destruction in peripheral arthritis triggered by physical injury. (1988) (32)
Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria. (2007) (32)
Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016) (32)
Behcet's syndrome in nonendemic regions (2017) (31)
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion. (2008) (31)
Longstanding isolated juvenile onset HLA-B27 associated peripheral enthesitis. (1992) (31)
Improvements in diagnostic tools for early detection of psoriatic arthritis (2016) (30)
Emerging drugs for psoriatic arthritis (2010) (30)
Clinical manifestations of seronegative spondylarthropathies. (1998) (30)
Measuring psoriatic disease in clinical practice. An expert opinion position paper. (2015) (30)
Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis. (2006) (30)
More on remitting seronegative symmetrical synovitis with pitting edema as paraneoplastic syndrome. (1998) (29)
Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumatica. (2004) (29)
Difficulties in the differential diagnosis between primitive rheumatic diseases and hepatitis C virus-related disorders. (2005) (29)
Low frequency of axial involvement in Caucasian pediatric patients with seronegative enthesopathy and arthropathy syndrome after 5 years of disease. (1992) (29)
Distal extremity swelling with pitting edema in psoriatic arthritis: evidence of 2 pathological mechanisms. (1999) (28)
The Definition and Measurement of Axial Psoriatic Arthritis (2015) (28)
Entheseal involvement. (2009) (28)
Hepatitis C virus infection in psoriatic arthritis. (2005) (28)
Transcutaneous electrical nerve stimulation in ankylosing spondylitis: a double-blind study. (1991) (28)
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology. (2017) (28)
Psoriatic disease: concepts and implications (2010) (28)
Psoriatic Disease 10 Years Later (2017) (28)
Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritis (2008) (27)
Trauma and seronegative spondyloarthropathy: report of two more cases of peripheral arthritis precipitated by physical injury. (1989) (27)
Management of reactive arthritis (2004) (27)
Can we reduce the dosage of biologics in spondyloarthritis? (2013) (26)
Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease. (2001) (26)
Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A. (1999) (26)
The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. (2002) (26)
RS3PE syndrome with unilateral involvement. (1994) (26)
Thrombosis associated with the prothrombin G-->A20210 mutation in Behçet's disease. (2000) (26)
Abatacept in spondyloarthritis refractory to tumour necrosis factor α inhibition (2008) (25)
Is Behçet's disease part of the spondyloarthritis complex? (1997) (25)
Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging (1998) (25)
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis. (2017) (25)
HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy. (1999) (24)
Magnetic resonance imaging in the diagnosis of PMR. (2000) (24)
Concomitant systemic lupus erythematosus and ankylosing spondylitis. (1990) (24)
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus. (2018) (24)
Infliximab in a case of early adult-onset Still’s disease (2003) (23)
Computed tomography of the sacroiliac joints in four patients with Behçet's syndrome--confirmation of sacroiliitis. (1990) (23)
Septic arthritis caused by Moraxella catarrhalis associated with infliximab treatment in a patient with undifferentiated spondarthritis (2003) (23)
Erythrocyte Sedimentation Rate and C-Reactive Protein in the Diagnosis of Polymyalgia Rheumatica (1998) (23)
Disease-modifying antirheumatic drug therapy for psoriatic arthritis. (2002) (22)
Hepatitis C virus infection in Italian patients with fibromyalgia (2007) (22)
Possible association between eosinophilic fasciitis and subcutaneous heparin use. (1998) (22)
Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept. (2009) (22)
Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. (2011) (22)
Isolated HLA-B27 associated Achilles tendinitis. (1987) (21)
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis. (2016) (21)
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy. (2017) (21)
Criteria, Frequency, and Duration of Clinical Remission in Psoriatic Arthritis Patients with Peripheral Involvement Requiring Second-line Drugs (2009) (21)
Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab. (2010) (21)
Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies. (1997) (21)
The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis (2000) (21)
Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross‐sectional study (2017) (21)
Dactylitis involving most of the fingers. (2003) (21)
Coexistence of ochronosis and ankylosing spondylitis. (1990) (20)
Long-lasting Remission of Severe Behçet’s Disease After the End of Infliximab Therapy (2009) (19)
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti‐TNF therapy: an Italian nationwide survey (2016) (19)
Ankylosing spondylitis with predominant involvement of the cervical spine in a woman with Behçet's syndrome. (1988) (19)
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis (2019) (19)
What is the primary lesion in SpA dactylitis? (2008) (18)
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. (2017) (18)
Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease. (2009) (18)
The Radiological Assessment of Axial Involvement in Psoriatic Arthritis (2012) (18)
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis. (2016) (18)
Isolated tenosynovitis associated with psoriasis triggered by physical injury. (1999) (18)
Rehabilitation for Ankylosing Spondylitis in the Era of Biologics: Any Room Left for This Treatment? (2011) (18)
Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete. (2008) (17)
Successful treatment of juvenile-onset HLA-B27-associated severe and refractory heel thesitis with adalimumab documented by magnetic resonance imaging. (2006) (17)
[Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]. (2011) (17)
Isolated juvenile onset HLA-B27 associated peripheral enthesitis. (1990) (17)
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease. (2012) (16)
Late-Onset Spondyloarthritis: Subset That Should Not Be Forgotten (2012) (16)
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review (2014) (16)
Worsening of psoriasis with rituximab therapy. (2010) (16)
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases (2018) (16)
Pharmacological therapy of spondyloarthritis (2015) (16)
Antibodies Directed against a Peptide Epitope of a Klebsiella pneumoniae-Derived Protein Are Present in Ankylosing Spondylitis (2017) (16)
Psoriatic arthritis: treatment strategies using biologic agents. (2012) (16)
Coexistence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: another report. (1987) (16)
Behçet's disease with unusual cutaneous lesions. (1998) (15)
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. (2017) (15)
Consensus on the management of patients with psoriatic arthritis in a dermatology setting (2018) (15)
Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab. (2010) (15)
The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis (2015) (15)
Spondyloarthritis and Diffuse Idiopathic Skeletal Hyperostosis: Two Different Diseases That Continue to Intersect (2013) (15)
Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agents. (2012) (15)
The “Macaroni Sign” of Takayasu’s Arteritis (2009) (15)
Safety of anti-tumor necrosis factor agents in psoriatic arthritis – an update (2014) (15)
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues. (2011) (15)
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis (2016) (15)
Concomitant ankylosing spondylitis and DISH. (1989) (15)
Ossification of the posterior longitudinal ligament in ankylosing spondylitis. (1988) (14)
Isolated HLA-B27 associated peripheral enthesitis. (1989) (14)
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study. (2013) (14)
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function (2017) (13)
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease (2010) (13)
Challenges and Advances in Targeting Remission in Axial Spondyloarthritis (2018) (13)
Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the article by Wagner et al. (2003) (13)
Colour duplex ultrasonography in the management of giant cell arteritis (2003) (12)
Elderly onset isolated B27 associated dactylitis (2002) (12)
Renal cell carcinoma mimicking polymyalgia rheumatica (2002) (12)
The triggering role of physical injury in the onset of peripheral arthritis in seronegative spondyloarthropathy (2005) (12)
Hip bursitis in active polymyalgia rheumatica: report of a case. (1999) (12)
Treatment strategies for early psoriatic arthritis (2009) (12)
Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis. (2016) (12)
Highlights of the 17th International Conference on Behçet's syndrome. (2016) (12)
Dactylolysis spontanea or ainhum involving the big toe. (2005) (12)
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement. (2019) (12)
Dactylitis of the thumb extending to the radial bursa. (2003) (12)
Pharmacoeconomic Issues in Psoriatic Arthritis (2012) (11)
Urticaria/arthritis syndrome: report of four B51 positive patients. (1989) (11)
GRAPPA 2011: Proceedings from the Ultrasound Imaging Module (2012) (11)
Classification of inflammatory arthritis (1998) (11)
Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. (2011) (11)
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study (2016) (11)
Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy. (1996) (11)
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease (2018) (11)
Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. (2018) (11)
Dactylitis also involving the synovial sheaths in the palm of the hand. (1994) (11)
Intervertebral disc lesions in diffuse idiopathic skeletal hyperostosis (DISH). (2001) (10)
Treatment strategies for early psoriatic arthritis. (2009) (10)
Psoriatic arthritis: Pharmacoeconomic considerations (2009) (10)
Coexisting ankylosing spondylitis and Paget's disease (1990) (10)
Management of hepatitis C virus-related arthritis (2005) (10)
Tarsal tunnel syndrome in seronegative spondyloarthropathy. (1989) (10)
[Recommendations for starting anti TNF-alpha in patients with ankylosing spondylitis]. (2011) (10)
Psoriatic arthritis in 2015: Advancement continues in imaging, tight control and new drugs (2016) (10)
Italian evidence-based recommendations for the management of ankylosing spondylitis: the 3E Initiative in Rheumatology. (2008) (9)
Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease. (2009) (9)
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs. (2014) (9)
Polyclonal B cell activation in ankylosing spondylitis. (1990) (9)
An update on the management of hepatitis C virus-related arthritis (2014) (9)
Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol (2018) (9)
Lack of association between chronic hepatitis C virus infection and Behçet's disease. (1997) (9)
Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis. (2012) (9)
Association between vitiligo and spondyloarthritis. (2001) (9)
Diffuse Achilles tendon thickening in juvenile onset seronegative HLA-B27 positive spondyloarthropathy. (1988) (9)
Enthesitis of spondylarthritis can masquerade as Osgood-Schlatter disease by radiographic findings. (2003) (8)
Symmetrical pitting edema resembling RS3PE in gout (2003) (8)
Conjunctival ulceration in Behçet's syndrome. (1992) (8)
Challenges in Economic Evaluation of Psoriatic Arthritis (2010) (8)
Behçet's syndrome and spondyloarthritis. (1990) (8)
Management of Behçet's dõsease: a systematõc lõterature revõew for the EULAR evõdence based Recommendatõons for the management of Behçet's dõsease (2008) (8)
Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study (2018) (8)
Juvenile onset isolated HLA-B27-associated dactylitis. (2003) (8)
The Journal of Rheumatology Volume 34 , no . 6 Dactylitis or " sausage-shaped " digit . (2007) (7)
Iliolumbar ligament ossification in undifferentiated seronegative spondyloarthropathy (1997) (7)
Polymyalgia rheumatica (1996) (7)
Coexisting Behçet’s Syndrome and Spondyloarthritis (1999) (7)
Ankylosing spondylitis with exuberant sclerosis in the sacroiliac joints, symphysis pubis and spine. (1990) (7)
Trauma and seronegative spondyloarthropathy. (1990) (7)
Ochronotic arthropathy of the spine limited to the thoracic section. (2013) (7)
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study (2009) (7)
SAT0368 A Systematic Literature Review on The Treatment of Major Organ Involvement of Behçet's Syndrome Informing The Eular Recommendations for The Management of Behçet's Syndrome (2016) (7)
Switching tumor necrosis factor alpha inhibitors in HLA-B27-associated severe heel enthesitis. (2007) (7)
Lateral epicondylitis with marked soft tissue swelling in spondyloarthritis (2004) (7)
Cervical myelopathy caused by ossification of the posterior longitudinal ligament in ankylosing spondylitis. (1996) (7)
Involvement of an inconstant bursa under the head of the second metatarsal bone in spondyloarthritis (2004) (7)
Seronegative spondylarthropathy without spine involvement in Behcet's syndrome (1993) (7)
Psoriatic arthritis. (1998) (6)
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement (2018) (6)
Pharmacological management of undifferentiated spondyloarthropathies (2006) (6)
[Pain patterns in Italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell'Artrosi)]. (2011) (6)
Cryoglobulinaemic vasculitis as presenting manifestation of infective endocarditis (2002) (6)
Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies (2017) (6)
Dactylitis of the thumb and the little finger extending to the carpal tunnel. (2007) (6)
Psoriatic arthritis and alpha-interferon. (2001) (6)
SAT0302 Clinical and Laboratory Features of Late-Onset Psoriatic Arthritis in Comparison with Younger-Onset Disease: Data from an Early Arthritis Cohort (2013) (6)
OP0110 Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force (2013) (6)
Golimumab for the treatment of axial spondyloarthritis (2017) (5)
THU0398 Observational Study on The Quality of Life of Italian Axial Spondyloarthritis Patients (QUASAR): Baseline Data (2016) (5)
Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. (2007) (5)
Raccomandazioni per il corretto uso degli agenti biologici bloccanti il TNF α nel trattamento dell'artrite psoriasica Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis (2004) (5)
Longstanding HLA-B27 associated Achilles tendinitis. (1992) (5)
Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives. (2017) (5)
Dactylitis with pitting oedema of the hand in longstanding ankylosing spondylitis (1995) (5)
Discussion: Assessment of psoriatic arthritis (2005) (5)
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. (2014) (5)
Imaging of psoriatic arthritis. (2011) (5)
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study. (2018) (5)
Retrocalcaneal bursitis in polymyalgia rheumatica (2001) (4)
Polymyalgia rheumatica [12] (1996) (4)
17th International Conference on Behçet's disease. (2016) (4)
Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists. (2016) (4)
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease. (2011) (4)
Tuberculous spondylitis as a cause of inflammatory spinal pain: a report of 4 cases. (1998) (4)
Toll-like receptor 4 ( TLR 4 ) gene polymorphisms in Italian patients with Behçet ’ s disease (2006) (4)
New Insights in Occult Psoriatic Arthritis (2012) (4)
Erosive immune complex-mediated arthritis associated with meningococcal meningitis. (1986) (4)
FRI0252 Behcet's Disease and Pregnancy: What is the Relationship? (2015) (4)
Relationship of Psoriatic Arthritis to Other Spondyloarthritides (2015) (4)
Juvenile onset psoriatic arthritis in a patient with X‐linked agammaglobulinemia (Bruton's disease) (2003) (4)
A national survey on the management of psoriatic arthritis using the Delphi method. (2016) (4)
Inconstant bursa between head of 5th metatarsal bone and tendon of abductor digiti minimi in psoriatic arthritis. (2002) (4)
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort (2017) (4)
Seronegative spondyloarthritides. (2002) (4)
Ileal pouchitis-related arthritis. (2002) (3)
CT and conventional radiography in detecting lysis and fracture of the odontoid process in rheumatoid arthritis. (1988) (3)
Acro-Osteolysis of the Big Toe in a Patient with Psoriatic Arthritis (2009) (3)
A brief course of anti-TNF-α therapy can cure recurrent episodes of HLA-B27-associated severe and refractory heel enthesitis. Author's reply (2009) (3)
FRI0254 Predictive Factors for the Response to Infliximab Therapy in Patients with Behçet's Disease (2015) (3)
Highlights of the 17 th International Conference on Behçet ’ s syndrome Matera , Italy , 15-17 September 2016 (2016) (3)
The extension of the ankylosing spondylitis "dagger sign" into the sacrum. (2000) (3)
Purpura and serum mixed cryoglobulinemia in psoriatic arthritis (2006) (3)
An Unusual Cause of Dysphagia (2012) (3)
Diagnosis and Management of Polymyalgia Rheumatica/Giant Cell Arteritis (2012) (2)
Coexisting diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis (1991) (2)
Artriti reattive: attualità in tema di diagnosi e terapia Reactive arthritis: advances in diagnosis and treatment (2002) (2)
A brief course of anti-TNF-alpha therapy can cure recurrent episodes of HLA-B27-associated severe and refractory heel enthesitis. (2009) (2)
Heel Enthesopathy of Diffuse Idiopathic Skeletal Hyperostosis Resembling Enthesitis of Spondyloarthritis (2010) (2)
Usefulness of plain film radiography in the diagnosis of dactylitis by history-taking. (2005) (2)
The prevalence of dysphonia and dysphagia in patients affected by immunomediated diseases and the role of psychometric tests (2018) (2)
Clinical images: transverse acroosteolysis. (2012) (2)
PLA 1 / A 2 polymorphism of platelet glycoprotein receptors IIIa in Behçet ’ s disease (2006) (2)
Undifferentiated seronegative spondyloarthropathy in females. (1996) (2)
The SAPHO Syndrome (2014) (2)
Psoriatic Arthritis and Psoriasis Projects in Italy: A Report from the GRAPPA 2011 Annual Meeting (2012) (2)
Non-rheumatoid erosive arthritis associated with type I hereditary angioedema (2005) (2)
Diffuse Idiopathic Skeletal Hyperostosis in an HLA-B27-Positive Subject. (2018) (2)
Ossification of the posterior longitudinal ligament in one of a pair of identical twins concordant for ankylosing spondylitis (1994) (2)
Corrigendum to “Measuring psoriatic disease in clinical practice. An expert opinion position paper” [Autoimmun. Rev. 14/10 (2015) p.864–874] (2016) (1)
Involvement of transitional lumbosacral joints in spondyloarthritis. (1999) (1)
Letters to the Editor. (2021) (1)
Systemic-onset juvenile idiopathic arthritis and HLA-B27 juvenile-onset undifferentiated spondyloarthritis in the same patient. (2013) (1)
Acute myositis in a patient with systemic sclerosis after the administration of darbepoetin alpha (2007) (1)
Shoulder sonographic findings in polymyalgia rheumatica. (1999) (1)
Psoriasis assessment tools in clinical trials. Discussion (2005) (1)
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study RHEUMATOLOGY (2015) (1)
SAT0387 Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Italian Patients with Psoriatic Arthritis, Psoriasis and Fibromyalgia –The ULISSE Study (2014) (1)
Protein Z G 79 A and A13 G gene polymorphisms in Italian patients with Behçet ’ s disease (2006) (1)
Can hepatitis C virus infection and interferon-alpha undo the HLA-DRB1*0402/DQB1*0302 protection against rheumatoid arthritis? (2003) (1)
PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY: A PROBABILISTIC SENSITIVITY ANALYSIS (2008) (1)
Carcinoid syndrome and ankylosing spondylitis. (1990) (1)
THU0236 The TNF Alpha -308 and the IL-6 -174 Promoter Polymorphisms Associate with Effective Anti-TNF Alpha Treatment in Seronegative Spondyloarthritis (2015) (1)
Cost-utility analysis of abatacept in rheumatoid arthritis in Italy (2008) (1)
Raccomandazioni per l'inizio della terapia con anti TNF-α α in pazienti con spondilite anchilosante Recommendations for starting anti TNF-α α in patients with ankylosing spondylitis (2003) (1)
AB1203-HPR Comparison of quality of life of patients with rheumatoid arthritis, psoriatic arthritis and ankilosing spondilitis with treatment or prescription of biologic drugs: results from the cara study (2017) (1)
ISSAS: International Start TNF-blocker Study in Ankylosing Spondylitis (2004) (1)
THU0611 Long-term follow-up of 269 children born to mothers with systemic autoimmune diseases: a national survey from 24 rheumatology centers (2017) (1)
Advantages in early recognition and treatment of psoriatic arthritis (2010) (1)
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. (2007) (1)
AB0781 High Sensitivity of the ASAS Classification Criteria in Patients with HLA-B27 Positive Undifferentiated Spondyloarthritis with Onset of Disease After Age 45 (2015) (1)
THU0634 Comparing preferences of patients with rheumatic diseases, of rheumatologists, nurses and pharmacists toward the treatment of rheumatic diseases with biological agents: results from the cara study (2017) (1)
[Reactive arthritis: advances in diagnosis and treatment]. (2011) (1)
Vasculitis 265. Cryoglobulinemic Vasculitis Secondary to Hepatitis C Infection: Is Prediction of Disease Severity Feasible? (2011) (0)
Efficacy of tumor necrosis factor alpha blockade for enthesitis in spondylarthropathy: comment on the article by Marzo-Ortega et al. (2002) (0)
Isolated HLA-B27associated Achilles tendinitis (1987) (0)
FRI0159 Longstanding active giant cell arteritis (gca) treated with infliximab: report of four casesinfliximab (2001) (0)
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis (2017) (0)
LRQFULWHULDDQG WR$6$6 recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis (2014) (0)
Urticaria/arthri tis syndrome: reportoffourB51 positive patients (1989) (0)
Comment on: HLA-B*2709 and spondylarthropathies. Authors' reply (2003) (0)
AB0731 Musculoskeletal but Not Skin Disease Activity Influence Rheumatologists Decision To Change Dmards or Biologic Therapy in Psoriatic Arthritis (2016) (0)
The pathophysiology of polymyalgia rheumatica [3] (multiple letters) (1999) (0)
Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept (2010) (0)
Parameters contributing to inflammatory back pain (IBP) according to experts (2005) (0)
Letters to the Editor (0)
CC chemokine receptor 5 polymorphism in Italian patients with Behc¸et’s disease (2012) (0)
Obituary: Professor Antonio Spadaro (2015) (0)
SAT0107 Simple Predictors of Abnormal 2h Postload Glucose in RA Patients with Normal Fasting Glucose (2016) (0)
Iconography : Aortitis and periaortitis in ankylosing spondylitis (2011) (0)
Ankylosing spondylitis with exuberant sclerosis or SAPHO syndrome? (1993) (0)
SAT0363 A Systematic Literature Review on The Treatment of Skin, Mucosa and Joint Involvement of Behçet's Syndrome Informing The Eular Recommendations for The Management of Behçet's Syndrome (2016) (0)
FRI0211 Serum carnitine measurement in primary raynaud’s phenomenon (2001) (0)
Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody (2008) (0)
Terapia E Imaging Follow-Up (2007) (0)
Psoriaticarthritis:treatmentstrategies usingbiologicagents (2012) (0)
Prevalence of rheumatic symptoms and findings in an inception cohort of Italian and Dutch IBD‐patients (1998) (0)
AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers (2017) (0)
Coexistence of primary biliary cirrhosis and isolated B27-associated peripheral enthesitis. (1998) (0)
SpondyloArthritis international Society (ASAS) exercise by experts from the Assessment of patients with chronic back pain: a real patient New criteria for inflammatory back pain in (2009) (0)
SP0198 Aberrant Spinal Bone Formation – As? Case Discussion (2015) (0)
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study (2016) (0)
Assessment of agreement of expert opinion on clinical features in axial spondyloarthritis (SpA) (2005) (0)
Magnetic resonance imaging and polymyalgia rheumatica. (2001) (0)
Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis. (2013) (0)
False dactylitis of the thumb (2003) (0)
SAT0739-HPR Patients' preferences toward characteristics of treatment with biological agents differ according to experience with their rheumatic disease and treatment received or prescribed: results from the cara study (2017) (0)
Persistent normalization of serum levels of uric acid in a gouty patient after administration of cyproterone acetate (2009) (0)
Prevalence of rheumatic symptoms and findings in an inception cohort of Italian and Dutch IBD-patients (1998) (0)
Coccygodinia as a possible presenting symptom of psoriatic arthritis. (2011) (0)
AB0785 The prevalence of behcet’s disease in basilicata (lucania) region of southern italy: preliminary results (2013) (0)
SAT0169 Frequency of Spondyloarthritis in Italian Patients with BehÇEt’S Disease (2013) (0)
Local injections in polymyalgia rheumatica. Authors' reply (2002) (0)
CC chemokine receptor 5 polymorphism in Italian patients with Behc¸et’s disease RHEUMATOLOGY (2012) (0)
The role of adalimumab in the treatment of heart block in HLA-B27-associated disease: a case description (2019) (0)
opinion including uncertainty appraisal (part I): classification of paper patients by expert classification criteria for axial spondyloarthritis SpondyloArthritis international Society The development of Assessment of (2009) (0)
Ankylosing spondylitis withpredominant involvement ofthecervical spine inawomanwith Behqet's syndrome (1988) (0)
Pure red aplasia induced by sodium valproate in a patient with Behçet's syndrome. (2017) (0)
Long-Term Efficacy of Infliximab for Treatment of Severe Behçet's Uveitis (2015) (0)
Diffuse Idiopathic Skeletal Hyperostosis in an HLA-B27–Positive Subject (2018) (0)
Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS) (2008) (0)
Patients’ Preferences Toward Characteristics of Treatment with Biological Agents Differ According to Experience with their Rheumatic Disease and Treatment Received or Prescribed: Results from the Cara Study (2016) (0)
Supernumerary metatarsal bone. (2006) (0)
AB0011 The Genetics of Behcet's Disease: a Novel Variation of Erap1 Gene in an Italian Cohort (2015) (0)
Recent advances in understanding and managing psoriatic arthritis (2019) (0)
SAT0168 Long Term Efficacy and Safety of Infliximab in the Treatment of BehÇEt’S Disease (2013) (0)
Polyclonal Bcell activation inankylosing spondylitis (1990) (0)
SPMO 8310 Ultrasonography and magnetic resonance in retrocalcanear bursitis (1997) (0)
Mature ovarian teratomas and the sacroiliac joints. (2008) (0)
SAT0040 Rheumatic diseases in patients with vitiligo: a study on 28 cases (2001) (0)
IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES (2009) (0)
The Journal of Rheumatology Volume 35 , no . 11 Role of Trauma in Psoriatic Arthritis (2008) (0)
THU0365 Do extra-articular manifestations affect the choice of biologic therapy in patients with axial spondyloarthritis? a multicentre real-life analysis (2017) (0)
polymyalgia rheumatica Cervical interspinous bursitis in active (2008) (0)

This paper list is powered by the following services:

Ignazio Olivieri's Academic­Influence.com Rankings

Ignazio Olivieri's Degrees

Why Is Ignazio Olivieri Influential?

Ignazio Olivieri's Published Works

Published Works

Ignazio Olivieri's AcademicInfluence.com Rankings